Stem Cell Therapy – Blue Horizon Stem Cells – Video
By raymumme
Stem Cell Therapy - Blue Horizon Stem Cells
By: Michael McDermott
The rest is here:
Stem Cell Therapy - Blue Horizon Stem Cells - Video
Uncategorized
Comments Off on Stem Cell Therapy – Blue Horizon Stem Cells – Video |
April 10th, 2013
Performance After Adipose Stem Cell Therapy for Horse – Cash Fuez and Flaxey – Video
By raymumme
Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey
Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey http://wichitaequinevet.com "This is the video of Flaxey after he and Cash won t...
By: WichitaEquine
Read more:
Performance After Adipose Stem Cell Therapy for Horse - Cash Fuez and Flaxey - Video
Uncategorized
Comments Off on Performance After Adipose Stem Cell Therapy for Horse – Cash Fuez and Flaxey – Video |
April 9th, 2013
Green Light to Genetic Engineering: The Monsanto Protection Act – Center for Research on Globalization
By Dr. Matthew Watson
 U.S. News & World Report | Green Light to Genetic Engineering: The Monsanto Protection Act Center for Research on Globalization GMO foods and ingredients are toxic. They're unsafe to eat. Independent studies prove it. Monsanto and other agribusiness giants want all animal and vegetable life forms patented. They want worldwide food control. Obama's has promised GMO labeling. Why Do GMO's Need Protection?New York Times (blog) Opinion: Monsanto decision shows legislators' lazinessUConn Daily Campus |
Uncategorized
Comments Off on Green Light to Genetic Engineering: The Monsanto Protection Act – Center for Research on Globalization |
April 7th, 2013
Laser Therapy Switches Cocaine Addiction On, Off in Rats: Study – U.S. News & World Report
By Dr. Matthew Watson
Indian Express | Laser Therapy Switches Cocaine Addiction On, Off in Rats: Study U.S. News & World Report In this study, the researchers used genetic engineering to insert light-sensitive proteins called rhodopsins into nerve cells (neurons) in the rats' prefrontal cortex. Activating this brain region with a laser tuned to the rhodopsins turned the neurons ... Zapping away cocaine addiction with laser lightGizmag Lasers Zap Cocaine AddictionDiscovery News Laser Light Zaps Away Cocaine AddictionUCSF Today Science World Report all 47 news articles » |
Uncategorized
Comments Off on Laser Therapy Switches Cocaine Addiction On, Off in Rats: Study – U.S. News & World Report |
April 7th, 2013
The 9 Levels Of Healthcare / Biotechnology And Who Should Invest – Part 1 – Seeking Alpha
By Dr. Matthew Watson
The 9 Levels Of Healthcare / Biotechnology And Who Should Invest - Part 1 Seeking Alpha The 9 Levels Of Healthcare / Biotechnology And Who Should Invest - Part 1. Apr 5 2013, 17:29 by: Brian Nichols | includes: BMRN, BMY, JNJ, NVS, PCYC, REGN. It can be very confusing to navigate the healthcare sector, more specifically those companies in ... |
Uncategorized
Comments Off on The 9 Levels Of Healthcare / Biotechnology And Who Should Invest – Part 1 – Seeking Alpha |
April 7th, 2013
Mumbai University to start courses in management, biotechnology … – Daily Bhaskar
By Dr. Matthew Watson
Mumbai University to start courses in management, biotechnology ... Daily Bhaskar Mumbai University will start courses in management, biotechnology, nanotechnology and food processing in Thane campus, which will be operational by 2014. Rs11 crore has been sanctioned for the Thane sub-centre and the state plans to build ... |
Uncategorized
Comments Off on Mumbai University to start courses in management, biotechnology … – Daily Bhaskar |
April 7th, 2013
BIL Gates And The BioBrick Foundation: A New Paradigm For Biotechnology? – Manufacturing.net
By Dr. Matthew Watson
 Manufacturing.net | BIL Gates And The BioBrick Foundation: A New Paradigm For Biotechnology? Manufacturing.net No, that's not a typo in the headline. I'm not talking about the founder of Microsoft, though he is no doubt the reason that biotechnology researcher Drew Endy decided to name his new computer-in-a-cell devices Boolean Integrase Logic gates (BIL for ... |
Uncategorized
Comments Off on BIL Gates And The BioBrick Foundation: A New Paradigm For Biotechnology? – Manufacturing.net |
April 7th, 2013
Roger Ebert and Evolution – What Does the DNA Tell Us? – Huffington Post (blog)
By Dr. Matthew Watson
Roger Ebert and Evolution - What Does the DNA Tell Us? Huffington Post (blog) In his original critique of a pro-ID film called eXpelled, Ebert combined an astute critique of creationist tactics with an exaggerated statement about Darwin's accomplishment and the fate of Darwinism in the days of molecular genetics and genome ... |
Uncategorized
Comments Off on Roger Ebert and Evolution – What Does the DNA Tell Us? – Huffington Post (blog) |
April 7th, 2013
Israeli researchers find food supplement can help fight Parkinson’s disease – Haaretz
By Dr. Matthew Watson
Haaretz | Israeli researchers find food supplement can help fight Parkinson's disease Haaretz Gil Ast of the university's Department of Human Molecular Genetics and Biochemistry has discovered that the supplement, known as phosphatidylserine, improves the function of genes involved in disorders such as familial dysautonomia Parkinson's disease. |
Uncategorized
Comments Off on Israeli researchers find food supplement can help fight Parkinson’s disease – Haaretz |
April 7th, 2013
Call to equip youth with IT education – The Nation
By Dr. Matthew Watson
 The Nation | Call to equip youth with IT education The Nation He was delivering lecture on opportunities for Pakistani scientists in the field of medicine at the concluding session of conference organized by Department of Microbiology and Molecular Genetics. Prof Shahida Hasnain, Vice Chancellor, Women University ... |
Uncategorized
Comments Off on Call to equip youth with IT education – The Nation |
April 7th, 2013
National Melanoma Summit media release: More public awareness of changing … – New Zealand Doctor Online
By Dr. Matthew Watson
National Melanoma Summit media release: More public awareness of changing ... New Zealand Doctor Online He says recently there have been remarkable results in treating advanced melanoma with targeted therapies based on molecular genetics - pills designed with knowledge derived from the molecular genetics revolution. "They work so well that people who are ... |
Uncategorized
Comments Off on National Melanoma Summit media release: More public awareness of changing … – New Zealand Doctor Online |
April 7th, 2013
“Patient experience with BRCA1/2 genetic testing: a thematic analysis of free … – IUPUI Newscenter
By Dr. Matthew Watson
“Patient experience with BRCA1/2 genetic testing: a thematic analysis of free ... IUPUI Newscenter April Hall, Genetics Counseling Graduate Student, Division of Clinical and Biochemical Genetics, Department of Medical and Molecular Genetics, IU School of Medicine, will present, "Patient experience with BRCA1/2 genetic testing: a thematic analysis of ... |
Uncategorized
Comments Off on “Patient experience with BRCA1/2 genetic testing: a thematic analysis of free … – IUPUI Newscenter |
April 7th, 2013
Tough Calls on Prenatal Tests – Wall Street Journal
By Dr. Matthew Watson
Wall Street Journal | Tough Calls on Prenatal Tests Wall Street Journal But there is a risk that aggressive marketing based on test performance from the early clinical trials could confuse physicians and patients with complex information, said Girish Putcha, a practicing molecular-genetics pathologist and former laboratory ... |
Uncategorized
Comments Off on Tough Calls on Prenatal Tests – Wall Street Journal |
April 7th, 2013
Another Tenderfoot – Natural History Magazine
By Dr. Matthew Watson
Natural History Magazine | Another Tenderfoot Natural History Magazine With the tools of molecular genetics at our disposal, even the most common birds can reveal fascinating secrets. Since my first trip in early 2011, I have traveled to New Guinea four times. When I returned from my last trip, my fieldwork completed, I ... |
Uncategorized
Comments Off on Another Tenderfoot – Natural History Magazine |
April 7th, 2013
Genetic instabilities a potential culprit for autism – Examiner.com
By Dr. Matthew Watson
 Examiner.com | Genetic instabilities a potential culprit for autism Examiner.com The study will be published in full in the upcoming edition of Human Molecular Genetics. According to the study, these genetic changes are caused by an overflow of DNA segments in hot spot areas, potentially affecting the possibility of a child ... |
Uncategorized
Comments Off on Genetic instabilities a potential culprit for autism – Examiner.com |
April 7th, 2013
StemCells, Inc., Rejects $20 Million from California Stem Cell Agency
By Dr. Matthew Watson
When does a financially struggling
biotech company turn down a $20 million “forgivable loan?”
When it is StemCells, Inc., of Newark,
Ca., and the cash is being offered by the $3 billion California stem
cell agency. The research program has handed out nearly 600 awards, and it is the first time that a recipient has rejected funding.
Ca., and the cash is being offered by the $3 billion California stem
cell agency. The research program has handed out nearly 600 awards, and it is the first time that a recipient has rejected funding.
That's the latest development in a stem
cell saga that began publicly last July and that involved unusual personal lobbying by the former chairman of the Golden State's stem cell research agency. The high point of the saga may have come in
September when the agency's governing board finished awarding
StemCells, Inc., $40 million in two different awards. But there was a
catch. StemCells Inc., had to match that figure with $40 million of
its own.
cell saga that began publicly last July and that involved unusual personal lobbying by the former chairman of the Golden State's stem cell research agency. The high point of the saga may have come in
September when the agency's governing board finished awarding
StemCells, Inc., $40 million in two different awards. But there was a
catch. StemCells Inc., had to match that figure with $40 million of
its own.
Late last month, StemCells, Inc., threw
in the towel on the $20 million awarded on its cervical spinal cord
injury application. In comments to analysts March 21, Rodney Young,
chief financial officer of the publicly traded company, said:
in the towel on the $20 million awarded on its cervical spinal cord
injury application. In comments to analysts March 21, Rodney Young,
chief financial officer of the publicly traded company, said:
“The funding would have been in the
form of a forgivable loan, however, we have elected not to borrow
these funds from CIRM(the stem cell agency).”
According to the Seeking Alpha transcript of the conference call with analysts, Young said,
“You may also recall that last
September, CIRM approved a separate application under the same
disease team program for Alzheimer's disease, which was also for up
to $20 million in the form of a loan. We remain in confidential
negotiations with CIRM regarding the terms and conditions that would
attach to this loan.”
The company provided no explanation for
rejecting the cash, either in the conference call transcript or in
its press release.
rejecting the cash, either in the conference call transcript or in
its press release.
During the conference call, StemCells,
Inc., reported continuing losses. For 2012, net losses totaled $28.5
million compared to $21.3 million in 2011. Revenue for 2012 was $1.4
million compared to $1.2 million in the previous year.
Inc., reported continuing losses. For 2012, net losses totaled $28.5
million compared to $21.3 million in 2011. Revenue for 2012 was $1.4
million compared to $1.2 million in the previous year.
The awards last year to StemCells,
Inc., founded by Stanford's eminent researcher Irv Weissman, stirred
up a bit of a ruckus. The spinal injury award was handed out
routinely in July. Scientific reviewers gave it a score of 79 and
recommended funding. It was another matter on the Alzheimer's
application. It was scored at 61. Reviewers said it did not merit
funding. But the company publicly appealed to the full board, which sent the
application back for more examination. It was rejected again.
Nonetheless, in September, the 29-member board approved the award on
a 7-5 vote, bypassing a rival Alzheimer's application scored at 63.
It was the first time in the eight-year-history of the agency that
its board approved an application that was rejected twice by
reviewers.
Inc., founded by Stanford's eminent researcher Irv Weissman, stirred
up a bit of a ruckus. The spinal injury award was handed out
routinely in July. Scientific reviewers gave it a score of 79 and
recommended funding. It was another matter on the Alzheimer's
application. It was scored at 61. Reviewers said it did not merit
funding. But the company publicly appealed to the full board, which sent the
application back for more examination. It was rejected again.
Nonetheless, in September, the 29-member board approved the award on
a 7-5 vote, bypassing a rival Alzheimer's application scored at 63.
It was the first time in the eight-year-history of the agency that
its board approved an application that was rejected twice by
reviewers.
Approval came only after strong
lobbying by Robert Klein, former chairman of the board. Klein was
also chairman of the ballot campaign that created the agency, and
Weissman, who holds stock in StemCells, Inc., and sits on its board,
was a major fundraiser for the campaign.
lobbying by Robert Klein, former chairman of the board. Klein was
also chairman of the ballot campaign that created the agency, and
Weissman, who holds stock in StemCells, Inc., and sits on its board,
was a major fundraiser for the campaign.
The Los Angeles Times' Pulitzer
Prize-winning columnist, Michael Hiltzik, wrote in October that
the process was “redolent of cronyism.” He said a
“charmed relationship” existed among StemCells, Inc., its
“powerful friends” and the stem cell agency.
Prize-winning columnist, Michael Hiltzik, wrote in October that
the process was “redolent of cronyism.” He said a
“charmed relationship” existed among StemCells, Inc., its
“powerful friends” and the stem cell agency.
As for the remaining $20 million award,
Martin McGlynn, CEO of StemCells, Inc., expects “quick” action on
finally securing the cash.
Martin McGlynn, CEO of StemCells, Inc., expects “quick” action on
finally securing the cash.
Here is an exchange that came during
the March conference call between McGlynn and analyst Kaey Nakae of
Ascendiant Capital Markets.
the March conference call between McGlynn and analyst Kaey Nakae of
Ascendiant Capital Markets.
Nakae: “Okay. Just 2 more questions.
I guess the first one, as it relates to CIRM.
In deciding to decline the funding for spinal cord yet continuing to
pursue the funding for Alzheimer's, is there a difference in what
you're getting from them in terms of potential terms and conditions
that allow you to proceed on one and not the other, or is it the fact
that you're already in human with -- in spine, and still very
preclinical with Alzheimer's?”
McGlynn: :”I think you're very
definitely -- you're getting at some important criteria when one
considers how to fund programs whether you use debt or equity,
etcetera. So I wouldn't disagree with anything that you've outlined
or surmised. But I just would pray your indulgence until we're
finished, the negotiations with CIRM, which are coming to a close and
we expect those to resolve pretty quickly with regards to the
Alzheimer's program. And then quite frankly, we can be way more
forthcoming and way more disclosive with regards not only to our
decisions, but to our thinking.”
StemCells, Inc., was trading at about $1.65 at the time of this writing, down slightly from the previous
day. Its 52-week high is $2.67 and its 52-week low $0.59.
day. Its 52-week high is $2.67 and its 52-week low $0.59.
Source:Stem Cell Therapy
Comments Off on StemCells, Inc., Rejects $20 Million from California Stem Cell Agency |
April 7th, 2013
Stem Cell Therapy for Pets – Teddy Before
By daniellenierenberg
Stem Cell Therapy for Pets - Teddy Before After
By: NewmanVets
Read the rest here:
Stem Cell Therapy for Pets - Teddy Before
Uncategorized
Comments Off on Stem Cell Therapy for Pets – Teddy Before |
April 6th, 2013
Stem Cell Therapy for Pets — Taylor Before
By daniellenierenberg
Stem Cell Therapy for Pets -- Taylor Before After
By: NewmanVets
Read more:
Stem Cell Therapy for Pets -- Taylor Before
Uncategorized
Comments Off on Stem Cell Therapy for Pets — Taylor Before |
April 6th, 2013
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video
By raymumme
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy PT assessment: 1) In walking, whole foo...
By: neurogenbsi
Originally posted here:
Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video
Uncategorized
Comments Off on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video |
April 4th, 2013
Stem cell therapy for AVN in India, Experience of patient from Canada – Video
By daniellenierenberg
Stem cell therapy for AVN in India, Experience of patient from Canada
Avascular necrosis also known as osteonecrosis, aseptic necrosis, and ischemic bone necrosis. It is a disease resulting from the temporary or permanent loss ...
By: StemRx BioScience
Read more here:
Stem cell therapy for AVN in India, Experience of patient from Canada - Video
Uncategorized
Comments Off on Stem cell therapy for AVN in India, Experience of patient from Canada – Video |
April 4th, 2013